Detail page

Knowledge Web

Person

Darius Ebrahimi-Fakhari (1985-)

Neurologe

Name	Darius Ebrahimi-Fakhari
Time	1985- (Date of birth and death)
Place	Gießen (Geburtsort) Heidelberg (Wirkungsort) Boston, Mass. (Wirkungsort) Deutschland
Gender	männlich
Academic degree	Dr. med.
Profession	Neurologe (characteristic profession) Kinderarzt Arzt
Variant	Darius Ebrahimi- Fakhari
Related	Klinikum Heidelberg Children's Hospital Medical Center (Boston, Mass.) (ab circa 2017-)
Further information	Diss. Medizinische Fakultät der Universität Heidelberg, Institut für Anatomie und Zellbiologie; Arzt, Klinik Kinderheilkunde I, Zentrum für Kinder- und Jugendmedizin Heidelberg, Universitätsklinikum Heidelberg; 2020 Harvard Medical School
Source	Internet
Record type	Person
GND-Identifier	1037282000
Record ID	1037282000
Involved in show all High-content screening identifies a small molecule that restores AP-4-dependent protein trafficking in neuronal models of AP-4-associated hereditary spastic paraplegia Startle Epilepsy Triggered By Maternal Cough Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4M1-associated hereditary spastic paraplegia (SPG50) Homozygous missense WIPI2 variants cause a congenital disorder of autophagy with neurodevelopmental impairments of variable clinical severity and disease course EPG5 Variants with Modest Functional Impact Result in an Ameliorated and Primarily Neurological Phenotype in a 3.5-Year-Old Patient with Vici Syndrome Author Correction: Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy Linking mitochondrial dysfunction to neurodegeneration in lysosomal storage diseases Molecular chaperones and protein folding as therapeutic targets in Parkinson’s disease and other synucleinopathies Clinical, morphological, biochemical, imaging and outcome parameters in 21 individuals with mitochondrial maintenance defect related to FBXL4 mutations Molecular chaperones and protein folding as therapeutic targets in Parkinson’s disease and other synucleinopathies Differential roles of the ubiquitin-proteasome-system and the autophagy-lysosomal-pathway in the degradation of α-synuclein [alpha-synuclein] in vivo : implications for Parkinson's disease and other neurodegenerative diseases

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Darius Ebrahimi-Fakhari (1985-)

High-content screening identifies a small molecule that restores AP-4-dependent protein trafficking in neuronal models of AP-4-associated hereditary spastic paraplegia

Startle Epilepsy Triggered By Maternal Cough

Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4M1-associated hereditary spastic paraplegia (SPG50)

Homozygous missense WIPI2 variants cause a congenital disorder of autophagy with neurodevelopmental impairments of variable clinical severity and disease course

EPG5 Variants with Modest Functional Impact Result in an Ameliorated and Primarily Neurological Phenotype in a 3.5-Year-Old Patient with Vici Syndrome

Author Correction: Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy

Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy

Linking mitochondrial dysfunction to neurodegeneration in lysosomal storage diseases

Molecular chaperones and protein folding as therapeutic targets in Parkinson’s disease and other synucleinopathies

Clinical, morphological, biochemical, imaging and outcome parameters in 21 individuals with mitochondrial maintenance defect related to FBXL4 mutations

Molecular chaperones and protein folding as therapeutic targets in Parkinson’s disease and other synucleinopathies

Differential roles of the ubiquitin-proteasome-system and the autophagy-lysosomal-pathway in the degradation of α-synuclein [alpha-synuclein] in vivo : implications for Parkinson's disease and other neurodegenerative diseases